Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059466) titled 'The Clinical Features and Underlying Neural Mechanisms of Late-Life Depression' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Late-Life Depression
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective is to clarify the clinical manifestations and neurological differences based on the age of onset in late-life depression (LLD).
Basic objectives2 - Others
Eligibility:
Age-lower limit - 60
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1.Individuals diagnosed with Major Depressive Disorder, either outpatients or inpatients in Keio University hospital.
2.Individuals 60 years of age or older at the time of informed consent.
3.Individuals who are clinically free of any overt neurodegenerative disorder at the time of informed consent.
4.Individuals who are capable of providing written informed consent for this study.
Key exclusion criteria - 1.Individuals with co-morbid disorders that are determined to be severe or significantly unstable.
2.Individuals with a history of head trauma or substance dependence.
3.Individuals with a pacemaker or other metallic implants.
4.Individuals with current or a history of epilepsy or generalized seizures.
5.Individuals judged as unsuitable for participation in this study by the investigators for any other reason.
Target Size - 200
Recruitment Status:
Recruitment status - Suspended
Date of protocol fixation - 2023 Year 03 Month 28 Day
Date of IRB - 2023 Year 03 Month 28 Day
Anticipated trial start date - 2023 Year 03 Month 28 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067998
Disclaimer: Curated by HT Syndication.
